PMID- 23029047 OWN - NLM STAT- MEDLINE DCOM- 20130306 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 9 DP - 2012 TI - The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure. PG - e45489 LID - 10.1371/journal.pone.0045489 [doi] LID - e45489 AB - A positive inotropic responsiveness to serotonin, mediated by 5-HT(4) and 5-HT(2A) receptors, appears in the ventricle of rats with post-infarction congestive heart failure (HF) and pressure overload-induced hypertrophy. A hallmark of HF is a transition towards a foetal genotype which correlates with loss of cardiac functions. Thus, we wanted to investigate whether the foetal and neonatal cardiac ventricle displays serotonin responsiveness. Wistar rat hearts were collected day 3 and 1 before expected birth (days -3 and -1), as well as day 1, 3, 5 and 113 (age matched with Sham and HF) after birth. Hearts from post-infarction HF and sham-operated animals (Sham) were also collected. Heart tissue was examined for mRNA expression of 5-HT(4), 5-HT(2A) and 5-HT(2B) serotonin receptors, 5-HT transporter, atrial natriuretic peptide (ANP) and myosin heavy chain (MHC)-alpha and MHC-beta (real-time quantitative RT-PCR) as well as 5-HT-receptor-mediated increase in contractile function exvivo (electrical field stimulation of ventricular strips from foetal and neonatal rats and left ventricular papillary muscle from adult rats in organ bath). Both 5-HT(4) mRNA expression and functional responses were highest at day -3 and decreased gradually to day 5, with a further decrease to adult levels. In HF, receptor mRNA levels and functional responses reappeared, but to lower levels than in the foetal ventricle. The 5-HT(2A) and 5-HT(2B) receptor mRNA levels increased to a maximum immediately after birth, but of these, only the 5-HT(2A) receptor mediated a positive inotropic response. We suggest that the 5-HT(4) receptor is a representative of a foetal cardiac gene program, functional in late foetal development and reactivated in heart failure. FAU - Brattelid, Trond AU - Brattelid T AD - Department of Pharmacology, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway. FAU - Qvigstad, Eirik AU - Qvigstad E FAU - Moltzau, Lise R AU - Moltzau LR FAU - Bekkevold, Silje V S AU - Bekkevold SV FAU - Sandnes, Dagny L AU - Sandnes DL FAU - Birkeland, Jon Arne K AU - Birkeland JA FAU - Skomedal, Tor AU - Skomedal T FAU - Osnes, Jan-Bjorn AU - Osnes JB FAU - Sjaastad, Ivar AU - Sjaastad I FAU - Levy, Finn Olav AU - Levy FO LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120920 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (RNA, Messenger) RN - 0 (Receptors, Adrenergic, beta) RN - 0 (Serotonin Plasma Membrane Transport Proteins) RN - 158165-40-3 (Receptors, Serotonin, 5-HT4) SB - IM MH - Animals MH - Female MH - Fetal Development/*genetics MH - Gene Expression Profiling MH - *Gene Expression Regulation, Developmental MH - Heart Failure/*genetics/metabolism MH - Heart Ventricles/*metabolism MH - Male MH - Myocardial Contraction/genetics MH - Phenotype MH - Pregnancy MH - RNA, Messenger/genetics/metabolism MH - Rats MH - Receptors, Adrenergic, beta/genetics/metabolism MH - Receptors, Serotonin, 5-HT4/*genetics/metabolism MH - Serotonin Plasma Membrane Transport Proteins/genetics/metabolism PMC - PMC3447799 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2012/10/03 06:00 MHDA- 2013/03/07 06:00 PMCR- 2012/09/20 CRDT- 2012/10/03 06:00 PHST- 2011/04/15 00:00 [received] PHST- 2012/08/23 00:00 [accepted] PHST- 2012/10/03 06:00 [entrez] PHST- 2012/10/03 06:00 [pubmed] PHST- 2013/03/07 06:00 [medline] PHST- 2012/09/20 00:00 [pmc-release] AID - PONE-D-11-06937 [pii] AID - 10.1371/journal.pone.0045489 [doi] PST - ppublish SO - PLoS One. 2012;7(9):e45489. doi: 10.1371/journal.pone.0045489. Epub 2012 Sep 20.